Literature DB >> 8520748

Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome.

R A Veldhuizen1, L A McCaig, T Akino, J F Lewis.   

Abstract

Changes in the surfactant system have been observed in patients with acute respiratory distress syndrome (ARDS). These alterations in surfactant are thought to contribute to lung dysfunction in this disease. In this report we describe the changes in surfactant subfractions in bronchoalveolar wash obtained from five patients with established ARDS compared with five non-ARDS patients. Our results show that, in addition to the changes in surfactant composition and yield reported previously, the ratio of small to large surfactant aggregates is significantly increased in patients with ARDS compared with non-ARDS patients (0.48 +/- 0.09 versus 0.20 +/- 0.05 respectively [p < 0.05]). This increased ratio was associated with a decreased level of SP-A in the large aggregate fraction. We suggest that this increased ratio represents a marker for surfactant alterations in ARDS that is independent of lavage technique and can be measured in a very small surfactant sample.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8520748     DOI: 10.1164/ajrccm.152.6.8520748

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  18 in total

1.  Surface tension in situ in flooded alveolus unaltered by albumin.

Authors:  Angana Banerjee Kharge; You Wu; Carrie E Perlman
Journal:  J Appl Physiol (1985)       Date:  2014-06-26

2.  Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS. Alterations in leukocytes, proteins, PAF and surfactant components.

Authors:  G Nakos; E I Kitsiouli; I Tsangaris; M E Lekka
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

3.  Defective surfactant secretion in a mouse model of Hermansky-Pudlak syndrome.

Authors:  Susan H Guttentag; Amana Akhtar; Jian-Qin Tao; Elena Atochina; Michael E Rusiniak; Richard T Swank; Sandra R Bates
Journal:  Am J Respir Cell Mol Biol       Date:  2005-03-24       Impact factor: 6.914

Review 4.  Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; D Willson; R H Notter
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

5.  Hyperoxia treatment of TREK-1/TREK-2/TRAAK-deficient mice is associated with a reduction in surfactant proteins.

Authors:  Andreas Schwingshackl; Benjamin Lopez; Bin Teng; Charlean Luellen; Florian Lesage; John Belperio; Riccardo Olcese; Christopher M Waters
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-24       Impact factor: 5.464

6.  Very low surfactant protein C contents in newborn Belgian White and Blue calves with respiratory distress syndrome.

Authors:  F Danlois; S Zaltash; J Johansson; B Robertson; H P Haagsman; M van Eijk; M F Beers; F Rollin; J M Ruysschaert; G Vandenbussche
Journal:  Biochem J       Date:  2000-11-01       Impact factor: 3.857

Review 7.  Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; Gloria S Pryhuber; Patricia R Chess; Bruce A Davidson; Paul R Knight; Robert H Notter
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

8.  LPS-treated macrophage cytokines repress surfactant protein-B in lung epithelial cells.

Authors:  Kiflai Bein; Michelangelo Di Giuseppe; Steven E Mischler; Luis A Ortiz; George D Leikauf
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

9.  Lung ventilation injures areas with discrete alveolar flooding, in a surface tension-dependent fashion.

Authors:  You Wu; Angana Banerjee Kharge; Carrie E Perlman
Journal:  J Appl Physiol (1985)       Date:  2014-07-31

Review 10.  Surfactant for pediatric acute lung injury.

Authors:  Douglas F Willson; Patricia R Chess; Robert H Notter
Journal:  Pediatr Clin North Am       Date:  2008-06       Impact factor: 3.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.